​

Aclaris Therapeutics (ACRS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Aclaris Therapeutics Revenue Highlights

Latest Revenue (Y)

$18.72M

Latest Revenue (Q)

$1.46M

Main Segment (Y)

License and Service

Aclaris Therapeutics Revenue by Period

Aclaris Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$18.72M-40.09%
2023-12-31$31.25M5.03%
2022-12-31$29.75M340.05%
2021-12-31$6.76M4.30%
2020-12-31$6.48M53.35%
2019-12-31$4.23M-58.11%
2018-12-31$10.09M499.58%
2017-12-31$1.68M100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31--

Aclaris Therapeutics generated $18.72M in revenue during NA 2024, up -40.09% compared to the previous quarter, and up 442.87% compared to the same period a year ago.

Aclaris Therapeutics Revenue by Quarter

DateRevenueChange
2025-03-31$1.46M-84.20%
2024-12-31$9.21M111.94%
2024-09-30$4.35M57.12%
2024-06-30$2.77M15.35%
2024-03-31$2.40M-86.35%
2023-12-31$17.57M89.29%
2023-09-30$9.28M396.63%
2023-06-30$1.87M-26.07%
2023-03-31$2.53M-67.39%
2022-12-31$7.75M-59.23%
2022-09-30$19.02M1144.63%
2022-06-30$1.53M5.16%
2022-03-31$1.45M-3.20%
2021-12-31$1.50M-9.52%
2021-09-30$1.66M-9.05%
2021-06-30$1.82M2.64%
2021-03-31$1.78M12.47%
2020-12-31$1.58M9.04%
2020-09-30$1.45M-29.18%
2020-06-30$2.05M45.42%
2020-03-31$1.41M28.49%
2019-12-31$1.09M11.39%
2019-09-30$983.00K-83.24%
2019-06-30$5.87M16.35%
2019-03-31$5.04M37.39%
2018-12-31$3.67M125.37%
2018-09-30$1.63M-55.71%
2018-06-30$3.68M228.80%
2018-03-31$1.12M11.91%
2017-12-31$999.00K46.05%
2017-09-30$684.00K100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30--

Aclaris Therapeutics generated $1.46M in revenue during Q1 2025, up -84.20% compared to the previous quarter, and up 8.28% compared to the same period a year ago.

Aclaris Therapeutics Revenue Breakdown

Aclaris Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Contract research$2.54M$3.04M$4.39M$5.83M-
License and Service$16.18M$28.21M$25.10M--
Other--$257.00K--
Other revenue---$931.00K-
Product----$424.00K
Rhofade Product----$424.00K

Aclaris Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: License and Service (86.43%), and Contract research (13.57%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25Dec 24Sep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
License and Service$1.33M$1.01M$10.74M$3.70M$1.74M$25.58M$994.00K$1.64M$6.72M$17.90M----------
Contract research$442.00K$445.00K$1.24M$645.00K$657.00K$1.27M$875.00K$889.00K$866.00K$1.09M$1.22M$1.22M$1.27M-------
Other--------$165.00K$30.00K----------
Other revenue----------$310.00K$232.00K$227.00K-------
Other Revenue-------------$244.00K$218.00K$242.00K$167.00K$118.00K$193.00K$218.00K
Laboratory Research Revenue-------------$1.42M$1.61M$1.53M$1.41M$1.33M$1.85M$1.19M

Aclaris Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: License and Service (75.13%), and Contract research (24.87%).

Aclaris Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ATLNAtlantic$442.61M$129.55M
HCATHealth Catalyst$306.58M$79.41M
STIMNeuronetics$74.89M$38.11M
MDXHMDxHealth$70.19M$19.83M
IVVDInvivyd$25.38M$11.30M
PREPrenetics Global$21.74M$6.41M
ACRSAclaris Therapeutics$18.72M$1.46M
PYXSPyxis Oncology$16.15M-
OBIOOrchestra BioMed$2.64M$836.00K
BIOABioAge Labs-$1.45M
VORVor Biopharma--

ACRS Revenue FAQ

What is Aclaris Therapeutics’s yearly revenue?

Aclaris Therapeutics's yearly revenue for 2024 was $18.72M, representing a decrease of -40.09% compared to 2023. The company's yearly revenue for 2023 was $31.25M, representing an increase of 5.03% compared to 2022. ACRS's yearly revenue for 2022 was $29.75M, representing an increase of 340.05% compared to 2021.

What is Aclaris Therapeutics’s quarterly revenue?

Aclaris Therapeutics's quarterly revenue for Q1 2025 was $1.46M, a -84.20% decrease from the previous quarter (Q4 2024), and a -39.32% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $9.21M, a 111.94% increase from the previous quarter (Q3 2024), and a -47.58% decrease year-over-year (Q4 2023). ACRS's quarterly revenue for Q3 2024 was $4.35M, a 57.12% increase from the previous quarter (Q2 2024), and a -53.18% decrease year-over-year (Q3 2023).

What is Aclaris Therapeutics’s revenue growth rate?

Aclaris Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -37.08%, and for the last 5 years (2020-2024) was 188.80%.

What are Aclaris Therapeutics’s revenue streams?

Aclaris Therapeutics's revenue streams in c 24 are Contract research, and License and Service. Contract research generated $2.54M in revenue, accounting 13.57% of the company's total revenue, down -16.28% year-over-year. License and Service generated $16.18M in revenue, accounting 86.43% of the company's total revenue, down -42.66% year-over-year.

What is Aclaris Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Aclaris Therapeutics was License and Service. This segment made a revenue of $16.18M, representing 86.43% of the company's total revenue.